Santen Pharmaceutical Co., Ltd. (SZD0) - Financials, balance sheet (quarterly)

9.80000 EUR

Last update Aug 1, 8:07 AM CEST

Market closed

Day range

9.80000

Previous close

9.80000

Open

9.80000

Access this stock data via API

Santen Pharmaceutical Co., Ltd.

9.80

Financials

Balance sheet

Fiscal date	Mar 2025	Sep 2024	Mar 2024	Dec 2023
Total assets	409.3B	409.1B	435.7B	—
Current assets	224.3B	218.5B	236.1B	—
Cash	—	—	—	—
Cash equivalents	—	—	—	—
Cash and cash equivalents	93.0B	84.4B	94.6B	—
Other short term investments	997M	1.5B	379M	—
Accounts receivable	71.8B	71.1B	90.5B	—
Other receivables	—	—	—	—
Inventory	51.6B	53.1B	43.2B	—
Prepaid assets	—	—	—	—
Restricted cash	—	—	—	—
Assets held for sale	—	—	—	—
Hedging assets	—	—	—	—
Other current assets	6.6B	8.4B	7.5B	—
Non current assets	185.0B	190.6B	199.6B	—
Properties	—	—	—	—
Land and improvements	—	—	—	—
Machinery furniture equipment	—	—	—	—
Construction in progress	—	—	—	—
Leases	—	—	—	—
Accumulated depreciation	—	—	—	—
Goodwill	75.5B	79.4B	83.8B	—
Investment properties	—	—	—	—
Financial assets	—	—	—	—
Intangible assets	75.5B	79.4B	83.8B	91.5B
Investments and advances	—	—	—	—
Other non current assets	2.5B	1.7B	1.8B	—
Total liabilities	124.1B	120.8B	130.3B	—
Current liabilities	86.8B	83.9B	92.8B	—
Accounts payable	39.0B	41.6B	43.5B	—
Accrued expenses	—	—	—	—
Short term debt	—	—	—	—
Deferred revenue	—	—	—	—
Tax payable	2.2B	2.7B	5.1B	—
Pensions	—	—	—	—
Other current liabilities	17.9B	13.4B	16.6B	—
Non current liabilities	37.3B	37.0B	37.5B	—
Long term provisions	670M	707M	687M	—
Long term debt	—	—	—	—
Provision for risks and charges	122M	371M	—	—
Deferred liabilities	2.6B	1.3B	1.4B	—
Derivative product liabilities	—	—	—	—
Other non current liabilities	1.7B	1.7B	1.7B	—
Shareholders equity
Common stock	8.8B	8.8B	8.8B	—
Retained earnings	228.3B	252.9B	240.0B	—
Other shareholders equity	—	—	—	—
Total shareholders equity	285.2B	288.3B	305.4B	—
Additional paid in capital	9.8B	9.4B	9.9B	—
Treasury stock	1.2B	24.5B	1.0B	—
Minority interest	-1.1B	-723M	-685M	—